GILD
Gilead Sciences Inc.
Company Overview
| Mkt Cap | $152.38B | Price | $119.79 |
| Volume | 10.03M | Change | +1.14% |
| P/E Ratio | 317.5 | Open | $116.06 |
| Revenue | $28.8B | Prev Close | $118.44 |
| Net Income | $480.0M | 52W Range | $86.08 - $124.61 |
| Div Yield | 3.16% | Target | $128.42 |
| Overall | 70 | Value | 60 |
| Quality | -- | Technical | 81 |
No chart data available
Stock Overview
Updated DailyGilead Sciences Inc. (GILD) is a leading Healthcare company in the Biotechnology industry, currently trading at $119.79 with a market capitalization of $152.38 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows GILD with a volume of 10.03 million shares. The stock opened down 2.01% from yesterday's close of $118.44. Current analyst estimates project earnings of $8.07 per share for this year, with next year targeting $8.5.
GILD demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including AMGN, VRTX, ABBV, BIIB, ILMN.
Key investment considerations for GILD include strong overall investment metrics. The company offers a dividend yield of 3.16% and analyst price targets suggest potential upside of 7.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:43 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $119.79 | +1.1% | 10.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |